NCT03686826View on ClinicalTrials.gov

Feasibility and Reliability of Multimodal Evoked Potentials

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

September 6, 2016

Primary Completion Date

September 15, 2017

Study Completion Date

December 31, 2018

Conditions
Multiple Sclerosis
Interventions
PROCEDURE

Acquisition of MEP und SSEP

Acquisition of MEP und SSEP at two different time points within 1 to 30 days

Trial Locations (1)

4031

Dep. of Neurology, Hospital of the University of Basel, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT03686826 - Feasibility and Reliability of Multimodal Evoked Potentials | Biotech Hunter | Biotech Hunter